Having trouble viewing this email? View in your browser.

28 March 2017

Dear colleagues,

In early 2016, ESCMID awarded Robert P. Ryan (Dundee, United Kingdom) one of three ESCMID Young Investigator Awards 2016. In late 2016, the University of Dundee has made us aware of their investigation against Robert Ryan, accusing him of research misconduct and poor professional practice. Based on these allegations ESCMID decided to withdraw the award.

We have a new ECC: the Laboratory Medicine and Research Institute of Bacterial Resistance at Yonsei University College of Medicine in Seoul, South Korea.

Are you looking for a new challenge? U.S. in vitro diagnostic company T2 Biosystems is looking for an energetic entrepreneurial person to join the commercial organization as Regional Account Manager based in Amsterdam.

Your ESCMID communications editors


More detail on ECCMID scientific programme available now

You can now download a pdf version of the ECCMID 2017 Programme Book. To make it easier to plan your schedule in Vienna we have added descriptions in ECCMIDlive so you better know what to expect at symposia, educational workshops and the keynote lectures. We have also scheduled three sessions for late-breaking abstracts: recent clinical trials on Saturday, vaccines on Sunday and diagnostics on Monday. We hope to see you all in Vienna!

› Read more

CMI highlight: Understanding antibiotic decision making in surgery

Researchers in the U.K. collected interviews and observational data from notes of six surgical teams at a teaching hospital to investigate antibiotic decision making during surgical ward rounds. The data indicated that surgeons’ antibiotic decisions come secondary to the surgical management of patients. Due to unclear responsibilities, lack of continuity and disjointed information, such decisions are often delegated, leading to sub-optimal antimicrobial management. In the face of increasing antibiotic resistance, the authors propose a position for a clinician who is specifically responsible for perioperative antibiotic management. (The paper is open access.)

› Read more

ESCMID Aspergillus guideline open for public consultation

The draft version of the medical guideline on the diagnosis and treatment of Aspergillus disease is now open for public consultation. The guideline is a result of the concerted efforts of ESCMID’s fungal infections study group (EFISG), the European Confederation of Medical Mycology (ECMM) and the European Respiratory Society (ERS).

If you want to comment on the manuscript you may write to the ESCMID Publications and Medical Guidelines Manager to request the (confidential) draft of the manuscript along with the comments form for listing feedback. We are happy to receive your feedback and comments by 9 May 2017. Please note that your comments and the authors’ responses to the comments will be published online with the guideline.

› Read more

ESGCD study group publishes newsletter on its activities

The newsletter includes an update on the study group’s participation in the European Clostridium difficile infection (CDI) surveillance, its proposal for the IMI-9 call, as well as guidance on infection prevention and control and faecal microbiota transplantation.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.